Daniel Lynch - Insider Trading & Ownership
-
Entity
-
Individual
-
Summary
-
The estimated net worth of Daniel Lynch is at least $14.7 M dollars as of May 17, 2024. Daniel Lynch is the Director of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $14.6 M. Daniel Lynch is the Director of 2seventy bio, Inc. and owns shares of 2seventy bio, Inc. (TSVT) stock worth about $145 K. Daniel Lynch is the Director of bluebird bio, Inc. and owns shares of bluebird bio, Inc. (BLUE) stock worth about $11.4 K.